Unique ID issued by UMIN | UMIN000052185 |
---|---|
Receipt number | R000056389 |
Scientific Title | A prospective study on clinical indicators that affect the rate of weight loss in allogeneic hematopoietic stem cell transplantation |
Date of disclosure of the study information | 2023/09/12 |
Last modified on | 2023/09/12 18:42:09 |
Single-center prospective pilot intervention study on clinical indicators influencing weight loss in allogeneic hematopoietic stem cell transplantation
Prospective study on weight loss rate in allogeneic hematopoietic stem cell transplantation
A prospective study on clinical indicators that affect the rate of weight loss in allogeneic hematopoietic stem cell transplantation
Prospective study on weight loss rate in allogeneic hematopoietic stem cell transplantation
Japan |
Hematopoietic tumor
Medicine in general |
Malignancy
NO
Exploring clinical indicators that affect the rate of weight loss in allogeneic hematopoietic stem cell transplantation
Safety
Exploratory
Pragmatic
Phase I
Identification of the optimal required calorimetric method
(Evaluate the relationship between the sufficiency rate obtained by dividing the total calorie supply during the period by the 5 types of basal metabolic calorie and the weight loss rate, and identify the optimal necessary calorie measurement method.)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Treatment
Food | Device,equipment |
Nutritional intervention
18 | years-old | <= |
70 | years-old | >= |
Male and Female
Patients undergoing allo-SCT using bone marrow catastrophic conditioning (busulfan 6.4 mg/kg, melphalan 140 mg/m2, whole body irradiation: multiple times 8 Gy) at Shizuoka Cancer Center Blood and Stem Cell Transplant Department.
Performance status (PS): PS 0 to 2 before transplantation.
Persons who provide explanations to patients themselves using explanatory documents and obtain written consent from the patients themselves.
Persons who are between 18 and 70 years of age at the time of obtaining consent.
Persons whose body mass index is 18.5 or more and less than 25.0 kg/m2 at the time of obtaining consent.
Simultaneous active multiple cancers.
Case with severe complications.
Cases of metastasis to the central nervous system with symptoms.
Case of pregnancy or breastfeeding.
Case with mental disorder.
Cases who answered that they were concerned about the amount of intake recorded on food tags.
Cases judged to be inappropriate by the attending physician.
20
1st name | Takashi |
Middle name | |
Last name | Aoyama |
Shizuoka Cancer Center
Dietary Department
411-8777
1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan
0559895222
t.aoyama@scchr.jp
1st name | Takashi |
Middle name | |
Last name | Aoyama |
Shizuoka Cancer Center
Dietary Department
411-8777
1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan
0559895222
t.aoyama@scchr.jp
Shizuoka Cancer Center
Japan Science and Technology Agency
Japanese Governmental office
Shizuoka Cancer Center
1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan
0559895222
t.aoyama@scchr.jp
YES
T2022-5-2023-1-4
Shizuoka Cancer Center
2023 | Year | 09 | Month | 12 | Day |
Partially published
Preinitiation
2023 | Year | 09 | Month | 04 | Day |
2023 | Year | 09 | Month | 04 | Day |
2024 | Year | 04 | Month | 01 | Day |
2027 | Year | 03 | Month | 31 | Day |
2023 | Year | 09 | Month | 12 | Day |
2023 | Year | 09 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056389